Using a noninfectious MVM surrogate for assessing viral clearance during downstream process development
2010 ◽
Vol 72
(1)
◽
pp. 34-39
◽
2010 ◽
Vol 105
(2)
◽
pp. 306-316
◽
2010 ◽
Vol 71
(3)
◽
pp. 356-366
◽
2009 ◽
Vol 66
(1)
◽
pp. 58-65
◽